Polycythemia vera (PV) is a blood cancer that begins in the marrow of your bones, the soft center where new blood cells grow. It causes your marrow to make too many red blood cells so your blood ...

Medically reviewed by Anju Goel, MD Blood cancers, a category that includes polycythemia vera (PV), are a risk factor for ...

How Does Polycythemia Vera Advance? Polycythemia vera affects your bone marrow, the spongy tissue in the center of your bones that makes blood cells. The disease causes your bone marrow to make ...

In part 3 of a discussion with Andrew Kuykendall, MD, Moffitt Cancer Center, he talks of rusfertide’s ability to enable patients to live a more viable life and free them from being tethered to the ...

Treatment guidelines in polycythemia vera currently recommend maintaining ... just at baseline, higher red blood cell masses, just the number of red blood cells they make, and also higher hematocrits.

Just like any chronic health condition, polycythemia vera (PV) can have a negative impact on your everyday life. Research has shown that PV is associated with a lower quality of life in measures ...

Takeda's $300 million wager on Protagonist Therapeutics' rusfertide for rare blood cancer polycythaemia vera (PV) appears to have paid off. The first phase 3 trial of the injectable hepcidin ...